30780869 27429849 21224061 26635725 20683666 23234477 21084431 25548921 22115851 24423326 19759136 27384222 25789503 36612173 26925962 22372600 32055496 23589525 30780889 19584719 26152149 26844838 27875099 20810568 21417853 21224073 22826467 2125266 - Search Results

Year	Number of Results
2009	2
2010	7
2011	14
2012	6
2013	6
2014	7
2015	7
2016	6
2017	2
2018	3
2019	4
2020	4
2022	2
2023	0

1

Abate EG, Smallridge RC. Abate EG, et al. Expert Rev Endocrinol Metab. 2011 Nov;6(6):793-809. doi: 10.1586/eem.11.76. Expert Rev Endocrinol Metab. 2011. PMID: 30780869

2

Peroxisome proliferator-activated receptor-γ agonist inhibits collagen synthesis in human keloid fibroblasts by suppression of early growth response-1 expression through upregulation of miR-543 expression.

Zhu HY, Bai WD, Wang HT, Xie ST, Tao K, Su LL, Liu JQ, Yang XK, Li J, Wang YC, He T, Han JT, Hu DH. Zhu HY, et al. Am J Cancer Res. 2016 Jun 1;6(6):1358-70. eCollection 2016. Am J Cancer Res. 2016. PMID: 27429849 Free PMC article.

3

RhoB loss prevents streptozotocin-induced diabetes and ameliorates diabetic complications in mice.

Bravo-Nuevo A, Sugimoto H, Iyer S, Fallon Z, Lucas JM, Kazerounian S, Prendergast GC, Kalluri R, Shapiro NI, Benjamin LE. Bravo-Nuevo A, et al. Am J Pathol. 2011 Jan;178(1):245-52. doi: 10.1016/j.ajpath.2010.11.040. Epub 2010 Dec 23. Am J Pathol. 2011. PMID: 21224061 Free PMC article.

4

Molecular Targeted Therapies of Aggressive Thyroid Cancer.

Ferrari SM, Fallahi P, Politti U, Materazzi G, Baldini E, Ulisse S, Miccoli P, Antonelli A. Ferrari SM, et al. Front Endocrinol (Lausanne). 2015 Nov 20;6:176. doi: 10.3389/fendo.2015.00176. eCollection 2015. Front Endocrinol (Lausanne). 2015. PMID: 26635725 Free PMC article. Review.

5

JNK-mediated transcriptional upregulation of RhoB is critical for apoptosis of HCT-116 colon cancer cells by a novel diarylsulfonylurea derivative.

Kim DM, Won M, Chung CS, Kim S, Yim HJ, Jung SH, Jeong S. Kim DM, et al. Apoptosis. 2010 Dec;15(12):1540-8. doi: 10.1007/s10495-010-0531-7. Apoptosis. 2010. PMID: 20683666

6

Targeting histone deacetylase in thyroid cancer.

Russo D, Durante C, Bulotta S, Puppin C, Puxeddu E, Filetti S, Damante G. Russo D, et al. Expert Opin Ther Targets. 2013 Feb;17(2):179-93. doi: 10.1517/14728222.2013.740013. Epub 2012 Dec 13. Expert Opin Ther Targets. 2013. PMID: 23234477 Review.

7

Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.

Kim BK, Kim HM, Chung KS, Kim DM, Park SK, Song A, Won KJ, Lee K, Oh YK, Lee K, Song KB, Simon JA, Han G, Won M. Kim BK, et al. Carcinogenesis. 2011 Mar;32(3):254-61. doi: 10.1093/carcin/bgq244. Epub 2010 Nov 17. Carcinogenesis. 2011. PMID: 21084431

8

Activation of the RhoB signaling pathway by thyroid hormone receptor β in thyroid cancer cells.

Ichijo S, Furuya F, Shimura H, Hayashi Y, Takahashi K, Ohta K, Kobayashi T, Kitamura K. Ichijo S, et al. PLoS One. 2014 Dec 30;9(12):e116252. doi: 10.1371/journal.pone.0116252. eCollection 2014. PLoS One. 2014. PMID: 25548921 Free PMC article.

9

RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer.

Vishnu P, Colon-Otero G, Kennedy GT, Marlow LA, Kennedy WP, Wu KJ, Santoso JT, Copland JA. Vishnu P, et al. Gynecol Oncol. 2012 Mar;124(3):589-97. doi: 10.1016/j.ygyno.2011.11.019. Epub 2011 Nov 22. Gynecol Oncol. 2012. PMID: 22115851 Free PMC article.

10

Update: the status of clinical trials with kinase inhibitors in thyroid cancer.

Wells SA Jr, Santoro M. Wells SA Jr, et al. J Clin Endocrinol Metab. 2014 May;99(5):1543-55. doi: 10.1210/jc.2013-2622. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423326 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results